West Pharmaceutical Services WST Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's investing cash flow?
- West Pharmaceutical Services (WST) reported investing cash flow of -$43.2M in Q2 2026.
- How has West Pharmaceutical Services's investing cash flow changed year-over-year?
- West Pharmaceutical Services's investing cash flow increased by 42.6% year-over-year, from -$75.2M to -$43.2M.
- What is the long-term trend for West Pharmaceutical Services's investing cash flow?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's investing cash flow has grown at a 3.1% compound annual growth rate (CAGR), from -$253.1M to -$285.9M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.